XML 37 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
Combined Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities:      
Net (loss) income $ (73,462,767) $ (78,172,611) $ 82,415,019
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:      
Net change in unrealized (appreciation) depreciation on commodity and cryptocurrency futures contracts (12,703,858) 33,905,514 29,744,871
Changes in operating assets and liabilities:      
Due from broker 30,627,611 (60,950,291) (613,126)
Interest receivable (93,245) (300,369) 0
Other assets 3,707 (8,069) (962)
Due to broker 0 (888,877) (26,389,281)
Management fee payable to Sponsor (155,982) 205,103 (36,930)
Payable for purchases of commercial paper 0 (13,050) (9,995,298)
Other liabilities 164,102 (37,523) 57,885
Net cash (used in) provided by operating activities (55,620,432) (106,260,173) 75,182,178
Cash flows from financing activities:      
Proceeds from sale of Shares 158,884,957 1,249,793,734 176,654,005
Redemption of Shares (264,948,395) (935,239,671) (297,814,864)
Net change in cost of the Underlying Funds 19,858,936 (26,443,537) (11,187,671)
Net cash (used in) provided by financing activities (86,204,502) 288,110,526 (132,348,530)
Net change in cash and cash equivalents (141,824,934) 181,850,353 (57,166,352)
Cash and cash equivalents, beginning of period 434,062,296 252,211,943 309,378,295
Cash and cash equivalents, end of period $ 292,237,362 $ 434,062,296 $ 252,211,943